NL-OMON53061已完成不适用
The role of intestinal microbiota in breast cancer treatment with hormone therapy: a pathway to new therapeutic options - Intestinal microbiota in breast cancer patients treated with hormonetherapy
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •* Postmenopausal estrogen receptor positive breast cancer patients in curative
- •setting starting with tamoxifen
- •* Willing and able to undergo all study procedures
- •* Signed informed consent
排除标准
- •* HER2+ breast cancer
- •* Metastatic disease (M+)
- •* Systemic therapy during previous month
- •* Prior therapeutic antibiotic use in last 3 months
- •* Physically or mentally incapable or incompetent to sign informed consent
研究者
相似试验
尚未招募
不适用
The role of intestinal microbiota in breast cancer treatment with hormone therapy: a pathway to new therapeutic optionsBreast Cancer - BorstkankerMicrobiota - DarmbacteriënEstrogen - OestrogeenHormone therapy - Hormonale therapieNL-OMON20717Maastricht University Medical Center (MUMC+)132
Unknown
不适用
Intestinal Microbiota of Breast Cancer Patients Undergoing ChemotherapyMicrobiotaNCT04138979First Affiliated Hospital of Harbin Medical University80
进行中（未招募）
不适用
Breast Cancer and Its Relationship With the MicrobiotaBreast CancerNCT03885648Universidad de Granada150
已完成
不适用
Engineering Gut Microbiome to Target Breast CancerBreast CancerNCT03358511Mayo Clinic7
已完成
不适用
Probiotics and Breast HealthBreast Cancer FemaleNCT03290651Lawson Health Research Institute60